Screening and Prospective Cohort Study of Risk Factors for Enhanced Recovery After Spinal Fusion Surgery in Advanced Age Patient
Launched by WUHAN UNION HOSPITAL, CHINA · Sep 7, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
To determine the high risk factors affecting accelerated recovery after spinal fusion surgery in elderly patients: a prospective cohort study
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Informed consent signed and dated by subject or guardian
- • 2. Commit to follow the research procedures and cooperate with the whole process of the study
- • 3. The subjects are 60 years old or older, regardless of gender
- • 4. Patients with degenerative spinal diseases requiring spinal fusion surgery
- • 5. Generally in good physical condition
- • 6. Able to adhere to and cooperate with research interventions, such as oral medication
- • 7. In fertile women, contraception should be used for at least one month prior to screening, and they should commit to use contraception throughout the study period and continue until the specified time after the study
- Exclusion Criteria:
- • 1. Acute infection
- • 2. Congenital malformation
- • 3. Abnormal anatomy or skeletal variation
- • 4. Malignant tumor
- • 5. The surgical area was locally infected with symptoms of local inflammation
- • 6. Fever or leukocytosis
- • 7. Morbid obesity
- • 8. Pregnant and nursing women
- • 9. Mental illness
- • 10. Acute joint disease, bone resorption, osteopenia and/or osteoporosis. Osteoporosis is a relative contraindication, as this condition may limit the degree of correction that can be produced, the amount of mechanical fixation, and/or the quality of the bone graft
- • 11. Patients who are unwilling to cooperate with post-operative treatment
- • 12. Any time an implant is performed it interferes with the anatomy or intended physiological function of the patient
About Wuhan Union Hospital, China
Wuhan Union Hospital, affiliated with Huazhong University of Science and Technology, is a leading medical institution located in Wuhan, China. Renowned for its comprehensive healthcare services and advanced research capabilities, the hospital plays a pivotal role in clinical trials aimed at enhancing medical knowledge and patient care. With a commitment to innovation and excellence, Wuhan Union Hospital collaborates with various stakeholders to conduct rigorous and ethically sound clinical research, contributing significantly to the advancement of medical science and public health both domestically and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported